Levy E, Margalith M, Sarov B, Sarov I, Rinaldo C R, Detels R, Phair J, Kaslow R, Ginzburg H, Saah A J
Virology Unit, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
J Med Virol. 1991 Nov;35(3):174-9. doi: 10.1002/jmv.1890350306.
The significance of serum IgG and IgA antibodies to cytomegalovirus (CMV) at various stages of human immune deficiency virus (HIV) infection was studied in 175 homosexual men. Sera were obtained from 123 HIV seropositives [41 asymptomatic, 29 with lymphadenopathy associated syndrome (LAS), 22 with AIDS related complex (ARC), and 31 AIDS patients], 17 HIV seroconverters, and 35 HIV asymptomatic seronegatives. The sera were tested blindly for CMV IgA and IgG antibodies using the immunoperoxidase assay (IPA) and CMV infected human embryo cells. Cross-sectional analysis of CMV IgG antibodies at a titer of greater than or equal to 20 showed 87% and 100% prevalence in the HIV seronegative groups and in the HIV seropositive groups, respectively (P less than 0.05). CMV IgG antibodies at a titer of greater than or equal to 80 were present in significantly higher proportions among the HIV seropositive subjects of the various groups as compared with the HIV seronegative homosexual men. However, in the HIV seronegatives who later seroconverted to HIV, a significantly higher prevalence of CMV antibodies (35%) was detected before HIV seroconversion, as compared with the persistently HIV seronegative subjects (14.3%) (P less than 0.05). The HIV seronegatives pre-HIV seroconversion also exhibited a significantly higher geometric mean titer (GMT) of CMV IgG antibodies (62.17 +/- 0.64) as compared with the persistently HIV seronegatives (34.0 +/- 0.6) (P = 0.03). Significantly higher GMTs of CMV IgG antibodies were detected in all the HIV seropositive groups as compared with the persistently HIV seronegative group. CMV IgG antibodies were not detected in the HIV seronegative subjects.(ABSTRACT TRUNCATED AT 250 WORDS)
在175名男同性恋者中研究了人免疫缺陷病毒(HIV)感染各阶段血清中抗巨细胞病毒(CMV)的IgG和IgA抗体的意义。血清取自123名HIV血清阳性者[41名无症状者、29名患淋巴结病相关综合征(LAS)者、22名患艾滋病相关综合征(ARC)者和31名艾滋病患者]、17名HIV血清转化者以及35名HIV无症状血清阴性者。采用免疫过氧化物酶测定法(IPA)和CMV感染的人胚细胞对血清进行CMV IgA和IgG抗体的盲测。对滴度大于或等于20的CMV IgG抗体进行横断面分析显示,HIV血清阴性组和HIV血清阳性组的患病率分别为87%和100%(P<0.05)。与HIV血清阴性的男同性恋者相比,各HIV血清阳性组中滴度大于或等于80的CMV IgG抗体比例显著更高。然而,在后来血清转化为HIV的HIV血清阴性者中,与持续HIV血清阴性者(14.3%)相比,在HIV血清转化前检测到的CMV抗体患病率显著更高(35%)(P<0.05)。与持续HIV血清阴性者(34.0±0.6)相比,HIV血清转化前的HIV血清阴性者CMV IgG抗体的几何平均滴度(GMT)也显著更高(62.17±0.64)(P=0.03)。与持续HIV血清阴性组相比,所有HIV血清阳性组中检测到的CMV IgG抗体GMT均显著更高。在HIV血清阴性者中未检测到CMV IgG抗体。(摘要截短于250词)